Asset Details
Do you wish to reserve the book?
Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
Do you wish to request the book?
Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Monitoring Gene Therapy with Herpes Simplex Virus Thymidine Kinase in Hepatoma Cells: Uptake of Specific Substrates
1997
Overview
This study investigates the application of PET with specific substrates for the assessment of enzyme activity after transfer of the herpes simplex virus thymidine kinase (HSV-tk) gene.
After transfection of a rat hepatoma cell line with a retroviral vector containing the HSV-tk gene, different clones were established by G418 selection. Uptake measurements were performed up to 48 hr in a TK-expressing cell line and in a control cell line using thymidine (TdR; measured under therapy conditions), fluorodeoxycytidine (FdCyt) and ganciclovir (GCV). Additionally, bystander experiments and inhibition/competition studies were done.
In TK-expressing cells GCV treatment caused an increased (up to 250%) TdR uptake in the acid-soluble fraction and a decrease to 5.5% in the acid-insoluble fraction. The FdCyt uptake was higher in the TK-expressing cells than in controls with a maximum after 4 hr (12-fold and 3-fold higher in the acid-insoluble and acid-soluble fraction). GCV accumulated up to 180-fold more in the acid-insoluble and 26-fold more in the acid-soluble fraction. GCV uptake occurred mainly by the nucleoside transport systems. Bystander experiments revealed a relation between growth inhibition or GCV uptake and the amount of TK-expressing cells. GCV uptake and growth inhibition were correlated with r = 0.96.
Assessment of GCV accumulation may serve as an indicator of the enzyme activity and of therapy outcome. TdR may be useful to measure therapy effects on DNA synthesis, whereas the potential of FdCyt has to be investigated in further studies.
Publisher
Soc Nuclear Med,Society of Nuclear Medicine
Subject
/ Antiviral Agents - pharmacology
/ Biological and medical sciences
/ Deoxycytidine Monophosphate - analogs & derivatives
/ Deoxycytidine Monophosphate - pharmacology
/ Dose-Response Relationship, Drug
/ Enzyme Inhibitors - pharmacology
/ Fluorescent Antibody Technique
/ Liver Neoplasms, Experimental - diagnostic imaging
/ Liver Neoplasms, Experimental - enzymology
/ Liver Neoplasms, Experimental - therapy
/ Pharmacology. Drug treatments
/ Tomography, Emission-Computed
/ Tritium
/ Tumor Cells, Cultured - diagnostic imaging
/ Tumor Cells, Cultured - drug effects
